2014

WuXi PharmaTech (NYSE: WX) Honored Among the BCG 50 Local Dynamos

    SHANGHAI, China, April 28 /Xinhua-PRNewswire-FirstCall/ -- WuXi
 PharmaTech (NYSE:   WX), a leading pharmaceutical, biotechnology and medical
 device research and development outsourcing company with operations in
 China and the United States, today proudly announced that it has been
 listed among "The BCG 50 Local Dynamos" by The Boston Consulting Group
 (BCG).
 
     (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
 
     BCG defines local dynamos as companies from rapidly developing
 economies (RDEs) that remain local and use truly innovative business models
 to conquer their domestic markets. BCG has identified six key success
 factors that distinguish these 50 local dynamos from their less successful
 competitors. These six factors are: customizing to local needs, devising
 innovative business models that overcome local challenges, leveraging the
 latest technologies, benefiting from low-cost labor and overcoming
 shortages of skilled labor, scaling up fast and sustaining long-term hyper
 growth without imploding.
 
     Among the 50 local dynamos, 15 are from China and WuXi PharmaTech is
 the only winner in the health care industry. Other China-based winners
 include Baidu.com, Ctrip.com International, Focus Media, New Oriental
 Education and Technology Group, and Shanda Interactive Entertainment.
 
     "We chose companies mainly based on their having an innovative business
 model," commented David Michael, the report's coauthor, Partner and
 Managing Director of BCG Greater China.
 
     "We are very pleased and honored to be one of The 50 Local Dynamos by
 BCG. With a vision to transform the global drug and medical device R&D
 model, WuXi PharmaTech is building a global R&D service platform that
 serves pharmaceutical, biotechnology and medical device companies
 worldwide," commented Dr. Ge Li, Chairman and Chief Executive Officer of
 WuXi PharmaTech. "We will continue our unremitting efforts to better serve
 clients and create value for our shareholders."
 
     About WuXi PharmaTech
 
     WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical
 device R&D outsourcing company, with operations in China and the United
 States. As a research-driven and customer-focused company, WuXi PharmaTech
 provides pharmaceutical, biotechnology and medical device companies a broad
 and integrated portfolio of laboratory and manufacturing services
 throughout the drug and medical device R&D process. WuXi PharmaTech's
 services are designed to assist its global partners in shortening the cycle
 and lowering the cost of drug and medical device R&D. For more information,
 please visit: www.wuxipharmatech.com.
 
 
For more information, please contact: Sherry Shao Tel: +86-21-5046-4002 Email: pr@pharmatechs.com

SOURCE WuXi PharmaTech

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.